Whereas most studies have focused on the role of FcγRIIB in the GC, recent developments have highlighted the role of extrafollicular B cell responses in SLE (28–30), necessitating an expanded analysis of the role of FcγRIIB in B cells. Here, FCGR2B is linked to systemic lupus erythematosus.